retatrutide eye side effects Extreme Followed Overdose of Unapproved Weight-Loss Drug Retatrutide Side Effects Research |
Description
This trial showed approximately 20% reduction in cardiovascular death, non-fatal myocardial infarction, and non-fatal stroke compared to placebo
LIFT quickly gained popularity in the USA, much to everyone's surprise, not just among its original target audience: VOL
It activates GLP-1, GIP, and glucagon receptors simultaneously
Since clinical trials and research for retatrutide are still in progress, there is no official or finalized dosing schedule yet
Clinical studies show that patients using GLP-1 medications can experience a weight loss of 1015% or more of their total body weight
